Branded

FDA approves Akebia Therapeutics’ Vafseo
Vafseo is used for the treatment of anemia due to chronic kidney disease in dialysis-dependent adult patients.
FDA approves Merck’s Winrevair
Winrevair is used for the treatment of adults with pulmonary arterial hypertension to increase exercise capacity, improve WHO functional class and reduce the risk of clinical worsening events.

FDA approves Gilead Sciences’ Biktarvy label update for pregnant adults with HIV

The updated label with additional data reinforces the safety and efficacy profile of Biktarvy to treat pregnant people with HIV-1 with suppressed viral loads, the company said.
Dr. Reddy's partners with Sanofi for vaccine brands in India

Dr. Reddy’s will have exclusive rights to promote and distribute Hexaxim, Pentaxim, Tetraxim, Menactra, FluQuadri, Adacel and Avaxim 80U.
Novo Nordisk gets FDA OK for new indication for Wegovy

Wegovy is now indicated to reduce the risk of serious heart problems in overweight or obese adults.
Gilead’s Biktarvy receives FDA OK for expanded indication

Biktarvy is the first and only INSTI-Based Single-Tablet regimen that is FDA approved and DHHS Guideline Recommended for people who are virologically suppressed with M184V/I resistance.
Viatris, Idorsia enter into global R&D collaboration

The R&D collaboration includes selatogrel, a cardiology medication, and cenerimod, a drug for the treatment of lupus.
AstraZeneca intros Airsupra

Airsupra (albuterol/budesonide) is the first and only FDA-approved anti-inflammatory rescue option for asthma.
Octapharma intros Balfaxar

Balfaxar is indicated for the urgent reversal of acquired coagulation factor deficiency induced by vitamin K antagonist (VKA, e.g., warfarin) therapy in adult patients.
Johnson & Johnson to acquire Ambrx Biopharma

The acquisition will advance next generation antibody drug conjugates to transform the treatment of cancer.

FDA approves Akebia Therapeutics’ Vafseo

FDA approves Merck’s Winrevair

FDA approves Gilead Sciences’ Biktarvy label update for pregnant adults with HIV

Dr. Reddy's partners with Sanofi for vaccine brands in India

Novo Nordisk gets FDA OK for new indication for Wegovy

Gilead’s Biktarvy receives FDA OK for expanded indication

Viatris, Idorsia enter into global R&D collaboration

AstraZeneca intros Airsupra

Octapharma intros Balfaxar

Johnson & Johnson to acquire Ambrx Biopharma